文献速递流行病学与生物统计临床试验与 GCP真实世界研究与卫生经济

单髁与全膝关节置换的患者相关结局:系统综述与荟萃分析

Patient relevant outcomes of unicompartmental versus total knee replacement: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2019-02-21

该系统综述纳入60项研究(6项随机对照试验的7篇文献、17项国家关节登记/数据库研究、36项队列研究),比较单髁膝关节置换(UKA)与全膝关节置换(TKA)在患者重要结局域的差异。UKA住院时间更短、功能评分更优,但5年翻修率更高;TKA在登记/数据库研究中死亡、静脉血栓栓塞和主要心脏事件风险更高。

要点

  • UKA住院时间显著短于TKA,功能PROM评分更优,但5年翻修率更高。
  • 登记/数据库研究中TKA的死亡、静脉血栓栓塞和主要心脏事件风险显著更高。
  • 两组疼痛PROM无显著差异;应基于上述结局与患者共同决策。

核心结论

  • TKA与UKA均为孤立性单间室骨关节炎的可行治疗选择。
  • 直接比较显示UKA在多个结局域结果更好,但TKA翻修风险更低。
  • 上述信息应作为患者共同决策选择治疗方案的依据。

研究设计与样本

  • 纳入60项研究:6项随机对照试验的7篇文献、17项国家关节登记/数据库研究、36项队列研究。
  • 纳入标准为过去20年发表的比较成人原发性UKA与TKA的研究;排除少于50例参与者或无法获得英文翻译的研究。
  • 系统综述注册号PROSPERO CRD42018089972。

主要发现

  • UKA住院时间显著短于TKA:随机对照试验组-1.20天(95%CI -1.67至-0.73),登记/数据库组-1.43天(95%CI -1.53至-1.33),队列组-1.73天(95%CI -2.30至-1.16)。
  • 基于PROM的疼痛无显著差异;UKA功能PROM评分在非试验组显著更优:登记/数据库组均数差-0.58(95%CI -0.88至-0.27),队列组-0.32(95%CI -0.48至-0.15)。
  • 登记/数据库研究中TKA的死亡风险比0.27(95%CI 0.16至0.45,指向UKA更低)、静脉血栓栓塞0.39(95%CI 0.27至0.57)、主要心脏事件0.22(95%CI 0.06至0.86)。
  • TKA因任何原因的早期再手术高于UKA。
  • 5年翻修率UKA在三个研究组均更高:风险比分别为5.95(95%CI 1.29至27.59)、2.50(95%CI 1.77至3.54)、3.13(95%CI 1.89至5.17)。

临床怎么用

  • 选择UKA或TKA时应向患者提供住院时间、功能、翻修及重大并发症风险的比较信息。
  • 对重视功能恢复和缩短住院的患者,UKA可能更优,但需告知5年翻修率更高的风险。
  • 对重视降低翻修风险的患者,TKA可能更合适,但需结合登记/数据库研究中较高的死亡、静脉血栓栓塞和主要心脏事件风险进行个体化评估。

局限性

  • 各结局域结果因数据水平而异,部分发现未达统计学显著性。
  • 随机对照试验、登记/数据库研究和队列研究结果并不完全一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To present a clear and comprehensive summary of the published data on unicompartmental knee replacement (UKA) or total knee replacement (TKA), comparing domains of outcome that have been shown to be important to patients and clinicians to allow informed decision making. DESIGN: Systematic review using data from randomised controlled trials, nationwide databases or joint registries, and large cohort studies. DATA SOURCES: Medline, Embase, Cochrane Controlled Register of Trials (CENTRAL), and Clinical Trials.gov, searched between 1 January 1997 and 31 December 2018. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Studies published in the past 20 years, comparing outcomes of primary UKA with TKA in adult patients. Studies were excluded if they involved fewer than 50 participants, or if translation into English was not available. RESULTS: 60 eligible studies were separated into three methodological groups: seven publications from six randomised controlled trials, 17 national joint registries and national database studies, and 36 cohort studies. Results for each domain of outcome varied depending on the level of data, and findings were not always significant. Analysis of the three groups of studies showed significantly shorter hospital stays after UKA than after TKA (-1.20 days (95% confidence interval -1.67 to -0.73), -1.43 (-1.53 to -1.33), and -1.73 (-2.30 to -1.16), respectively). There was no significant difference in pain, based on patient reported outcome measures (PROMs), but significantly better functional PROM scores for UKA than for TKA in both non-trial groups (mean difference -0.58 (-0.88 to -0.27) and -0.32 (-0.48 to -0.15), respectively). Regarding major complications, trials and cohort studies had non-significant results, but mortality after TKA was significantly higher in registry and large database studies (risk ratio 0.27 (0.16 to 0.45)), as were venous thromboembolic events (0.39 (0.27 to 0.57)) and major cardiac events (0.22 (0.06 to 0.86)). Early reoperation for any reason was higher after TKA than after UKA, but revision rates at five years remained higher for UKA in all three study groups (risk ratio 5.95 (1.29 to 27.59), 2.50 (1.77 to 3.54), and 3.13 (1.89 to 5.17), respectively). CONCLUSIONS: TKA and UKA are both viable options for the treatment of isolated unicompartmental osteoarthritis. By directly comparing the two treatments, this study demonstrates better results for UKA in several outcome domains. However, the risk of revision surgery was lower for TKA. This information should be available to patients as part of the shared decision making process in choosing treatment options. SYSTEMATIC REVIEW REGISTRATION: PROSPERO number CRD42018089972.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Wilson HA, Middleton R, Abram SGF, et al. Patient relevant outcomes of unicompartmental versus total knee replacement: systematic review and meta-analysis. BMJ. 2019. PMID: 30792179. doi:10.1136/bmj.l352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。